Self-funded, non-profit medical research organisation and charity LifeArc has announced today that it is to launch the Rare Disease Translational Challenge, which will invest over £100 million by ...

Bkemv is being offered at 10% off Soliris, and Epysqli is offered at 30% below Soliris. Both biosimilars treat several of the ...

A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability ...

Amvuttra (vutrisiran) Transthyretin-directed small interfering RNA therapeutic Treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce ...

Eli Lilly CEO David Ricks to the BBC: “It feels like it'll be hard to come back from here." The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as ...

Amvuttra (vutrisiran) Transthyretin-directed small interfering RNA therapeutic Treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce ...

Approval of the Opdivo plus Yervoy combination regimen was based on results from the Phase III CheckMate-8HW trial, which was the largest immunotherapy study in patients with previously untreated, ...

Věděli jste, proč je důležité agresorovi vykat a jak naše ruce dokážou vyřešit až 90 % konfliktů? Instruktorka také ukázala, které obranné prostředky skutečně fungují a které ne. Jak šli základy ...

Best Phones Under 10,000 Best Phones Under 15,000 Best Phones Under 20,000 Best phones in any price range ...